Otteliones A and B, isolated from the freshwater plant Ottelia alismoides, have attracted significant attention because of their potential as novel anticancer agents. In this review, four independent enantioselective total syntheses and one formal synthesis of these natural products are presented with particular focus on their methodology and strategy.
In late 1998, Ayyad et al. reported the isolation and structural elucidation of two diastereomeric natural products, otteliones A (1) and B (2) (Figure 1 ), from the freshwater plant Ottelia alismoides collected from the irrigation channels of the Nile Delta in Egypt [1] . These natural products were found to exhibit quite potent antiproliferative activity with IC 50 values in the range from nanomolar (nM) to picomolar (pM) levels against a panel of 60 human cancer cell lines at the National Cancer Institute in the United States [1] . It has also been reported that 1 inhibits tubulin polymerization into microtubules in a similar way to the wellknown alkaloids colchicine, vincristine, and vinbrastine [2, 3] . In addition, 1 has been shown to inhibit doxorubicin-resistant leukemia cells (P388/DOX) with an IC 50 value of 3.0 nM [1] . Otteliones, therefore, are strongly expected to be promising new leads for the development of cancer chemotherapeutic agents. However, further biological studies of these natural products are severely limited by the scarcity of samples from O. alismoides (0.0009% isolated yield) [1] . Structurally, 1 and 2 possess a novel bicyclic hydrindane skeleton with four contiguous asymmetric carbon centers, wherein the rare and sensitive 4-methylene-2-cyclohexenone substructure is a special characteristic feature [1] . At the time when these natural products were isolated, the relative configuration of 2 was elucidated, as shown in formulation 2; however, 1 could not be unambiguously assigned, and both formulations 3 and 4 were proposed as possible stereostructures, with a greater preference for formulation 3 [1] . In 2000, scientists from Rhône-Poulenc Rorer (now Sanofi-Aventis) proposed an alternative stereostructure for 1, which was assigned by extensive spectroscopic studies including two dimensional nuclear magnetic resonance (NMR) experiments (correlation spectroscopy, heteronuclear multiple quantum coherence, heteronuclear multiple bond correlation, nuclear Overhauser effect spectroscopy, and rotating frame nuclear Overhauser effect spectroscopy measurements) [4] , while its absolute configuration was not determined.
Their powerful antitumor activities, unique structural features, and limited availability from natural resources, as well as the need to confirm the absolute configuration, have made the otteliones exceptionally intriguing and timely targets for a total synthesis. A number of synthetic studies of 1 and 2 have been reported to date [5] [6] [7] [8] [9] [10] [11] [12] [13] . In 2002, the first total synthesis of racemic (±)-1 and (±)-2 was reported by Mehta et al., which verified their relative stereochemistry [14] . In the following year, Mehta and our groups independently achieved the first enantioselective total synthesis of naturally occurring (+)-1 and (−)-2, leading to the establishment of their absolute configurations [15] [16] [17] . Recently, two additional total syntheses of (+)-1 and (−)-2 were reported by Clive et al. in 2007 [18, 19] and Sha et al. in 2010 [20] , respectively. In addition, the formal total synthesis of (+)-1 and (−)-2 was also reported by Ryu et al. in 2008 [21] . In this paper, enantioselective total syntheses of 1 and 2 are reviewed, with particular focus on their methodology and strategy.
Our total synthesis
Synthetic strategy: In 2003, we reported the first total synthesis of naturally occurring (+)-1 and (−)-2 at almost the same time as Mehta's paper was published (vide infra) [16, 17] . Our retrosynthetic plan is outlined in Scheme 1. The key feature of this plan is the utilization of the highly and appropriately functionalized intermediate 7, which contains the requisite bicyclic cis-hydrindane skeleton possessing the correct stereochemistry at the C3, C3a, and C7a positions, as well as the desirable functionalities for elaboration of the target molecules 1 and 2. The 4-methylene-2-cyclohexenone substructure present in 1 and 2 was highly expected to be sensitive; therefore, we decided to construct this substructure in the final stage of the synthesis. Since the C1 formyl group of 7 is masked as an internal hemiacetal moiety, intermediate 6 would be elaborated through the coupling of 7 with the aryllithium generated from aryl bromide 8 (the aromatic portion) (7 + 8 → 6). Intermediate 6 would be converted into the target molecules 1 and 2 through the advanced key intermediate 5 by sequential functional group manipulation and deprotection or vice versa. The sequence involves base-induced hemiacetal-opening/epimerization at the masked C1 formyl group and deoxygenation of the C10 hydroxy group, followed by the formation of the 4-methylene-2-cyclohexenone substructure. Intermediate 7 should in turn be accessed from the known tricyclic compound 9, which was prepared in our laboratories by Diels-Alder cycloaddition of optically active cyclohexenone 10 with cyclopentadiene (11) [22] [23] [24] or iridium-catalyzed oxidative desymmetrization of meso-diol 12 [25, 26] .
Total synthesis: At first, as shown in Scheme 2, we pursued the synthesis of intermediate 7 starting from the known enantiomerically pure tricyclic compound 9 [22] [23] [24] [25] [26] . Thus, stereoselective reduction of the carbonyl group in 9 with NaBH 4 provided alcohol 13 in 87% yield as a single stereoisomer. Subsequent Lemieux-Johnson oxidation of 13 furnished cyclic hemiacetal 7 in 75% yield via the intermediate dialdehyde 14.
We next investigated the synthesis of intermediate 5, as shown in Scheme 3. Thus, the crucial coupling reaction of aldehyde 7 with the aromatic portion 8 (cf. Scheme 1) cleanly and smoothly proceeded to give the desired products 6a (80% yield) and 6b (20% yield) as a mixture of epimeric alcohols, which were separated by silica gel column chromatography. Subsequent hemiacetalopening/epimerization reaction of 6a provided hydroxy aldehyde 15 in 65% yield (based on recycling four times). Intermediate 15 was then converted to diol 16 in 89% overall yield via a three-step operation including reduction of the formyl group followed by triacetylation and Birch reduction. Simultaneous oxidation of the primary and secondary hydroxy groups in 16 furnished the corresponding keto aldehyde 17 in 90% yield, which was then subjected to twofold Wittig methylenation to give the requisite key intermediate 5 in 95% yield.
The final route that led to the completion of the total synthesis of the targeted (+)-1 and (−)-2 is summarized in Scheme 4, which involves the crucial elaboration of the highly sensitive 4-methylene-2-cyclohexenone substructure. To this end, simultaneous deprotection of the acetonide moiety and the methoxymethyl (MOM) group in the key intermediate 5 followed by chemoselective acetylation of the phenolic hydroxy group in the resulting triol afforded monoacetate 18 in 78% yield for the two steps. Installation of the C5-C6 double bond was achieved by employing the Corey-Winter's protocol [27, 28] . Thus, formation of cyclic thiocarbonate 19 followed by exposure to refluxing triethyl phosphite resulted in the production of the requisite diene 20 in 73% overall yield. Simultaneous deprotection of the tert-butyldimethylsilyl (TBS) and acetyl groups in 20 by treatment with tetra-n-butylammonium fluoride (TBAF) followed by chemoselective reprotection of the liberated phenolic hydroxy groups furnished dichloroacetate 21 in 66% yield for the two steps. Finally, compound 21 was converted to (
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Mehta's total synthesis
Synthetic strategy: In 2002, Mehta et al. reported the first total synthesis of racemic (±)-1 and (±)-B (2), which led to determination of their relative stereostructures [14] . In the following year, the same research group presented the first enantioselective total synthesis of (+)-1 and (−)-2, which established their absolute configurations [15] . Their retrosynthetic plan, which relies on their racemic synthesis, is illustrated in Scheme 5. The crucial step is envisaged to be the coupling reaction of the tricyclic intermediate 24 with the aromatic portion 25 to assemble the requisite carbon framework such as structure 23 ( Katoh the two steps. The crucial coupling reaction of 24 with the aromatic portion 25 (cf. Scheme 5) was efficiently achieved by the halogen/metal exchange of 4-bromo-1-methoxy-2-(tertbutyldimethylsiloxy)benzene (25) with n-BuLi in tetrahydrofuran (THF) at −78°C followed by the addition of 24 at the same temperature (−78°C → rt); the desired coupling product 23 was obtained in 88% yield. 
Clive's total synthesis
Synthetic strategy: In 2007, Clive et al. reported the third total synthesis of (+)-1 and (−)-2) [18, 19] . The retrosynthetic plan is shown in Scheme 9. The most crucial step in this scheme is envisaged to be a ring-closing metathesis (RCM) of tetraenes 33a,b to construct the requisite 4-methylene-2-cyclohexenone substructure (33a, b → 1 and 2) . Total synthesis: As shown in Scheme 10, the synthesis commenced with the preparation of intermediate 38 starting from the known furanose derivative 41 [32] . Thus, iodination of 41 (86% yield) followed by treatment with zinc in MeOH furnished aldehyde 42, which was allowed to react with vinylmagnesium bromide to give a mixture of epimeric alcohols 43 in 73% yield in two steps. Subsequent RCM reaction of 43 and PCC oxidation furnished cyclopentenone 40 in 79% overall yield. Stereoselective cyclopropanation of 40 was successfully achieved by reaction with (carboethoxymethyl)dimethylsulfonium bromide (EtO 2 CCH 2 S + Me 2 Br − ) in the presence of DBU, leading to the desired product 44 in 92% yield. Compound 44 was then converted to the key intermediate 38 in 59% overall yield via a three-step process including acidic hydrolysis of the acetonide moiety, dimesylation of the liberated two hydroxy groups, and hydrogen reduction. 
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With the first key intermediate 38 in hand, the synthesis of the second key intermediate 35 was performed as shown in Scheme 11. Thus, the crucial aldol coupling of 38 with the aromatic portion 39 (cf. Scheme 9) cleanly proceeded in a completely diastereoselective manner at the C3 position, providing the desired coupling product 45 in 91% yield as a mixture of epimeric alcohols. Sequential deoxygenation of the C10 hydroxy group in 45, reduction of both the carbonyl and ester moieties, selective pivaloylation of the resulting primary hydroxy group, and reoxidation of the remaining secondary hydroxy group, produced cyclopropyl ketone 37 in 67% overall yield. The critical cyclopropane ring opening of 37 was achieved by treatment with SmI 2 in THF/MeOH to give the desired product 36 in 82% yield. This was deprotonated with KN(SiMe 3 ) 2 under kinetic conditions, and the enolate generated in situ was quenched with Comins' triflating reagent [N-(5-chloro-2pyridyl)bis(trifluoromethanesulfonimide)] [33] to give the corresponding enol triflate 46 in 92% yield. Subsequent methoxycarbonylation of 46 under standard conditions delivered the desired methyl ester 47 (77% yield), which was then converted to the second key intermediate 35 in 93% overall yield by DIBAL reduction followed by Dess-Martin oxidation. After obtaining the second key intermediate 35, the final route that led to completion of the total synthesis of (+)-1 was investigated as shown in Scheme 12. Thus, conjugate addition of the cuprate (prepared in situ from chloroprene) to enal 35 was successfully achieved in the presence of Me 3 SiCl and HMPA at −78°C; the desired product 34a was obtained in 61% yield upon acidic work up. This product possesses the correct stereochemistry at both the C3a and C7a positions. A subsequent reaction of 34a with vinylmagnesium bromide provided a mixture of allylic alcohols 33a in 69% yield. The most crucial RCM reaction of tetraene 33a was efficiently achieved using Grubbs I catalyst [bis(tricyclohexylphosphine)benzylidene ruthenium(IV) dichloride] (5 mol%) [34] in CH 2 Cl 2 at room temperature, which led to the formation of the desired cyclized product 48 in 93% yield. Finally, Dess-Martin oxidation of 48 followed by desilylation provided the target (+)-1 {[α] D = +19.7 (c 0.28, CHCl 3 )} in 76% yield for the two steps. 
Sha's total synthesis
Synthetic strategy: Sha et al. reported the fourth total synthesis of (+)-1 and (−)-2 in 2010 [20] . Their retrosynthetic analysis is illustrated in Scheme 14. The first crucial step is envisaged to be the Suzuki-Miyaura coupling [35] between organoborane 51 (accessible from olefin 53) and aryl iodide 52 to incorporate the aromatic portion into a bicyclic cis-hydrindane skeleton (51 + 52 → 50). The coupling product 50 would be converted to the target molecules 1 and 2 via the advanced key intermediate 49 by sequential functional group manipulation and deprotection or vice versa. The second crucial step is envisaged to be the radical cyclization of α-iodoketone 54 to construct the bicyclic cishydrindane skeleton (54 → 53). Intermediate 54 was to be prepared from the known cyclohexenone 55 [36] . Total Synthesis: At first, as shown in Scheme 15, the synthesis of intermediate 53 (the key precursor for the Suzuki-Miyaura coupling reaction) was investigated starting from the known optically active cyclohexenone derivative 55, which was previously prepared from commercially available (−)-quinic acid by Danishefsky et al. [36] Thus, the reaction of 55 with the cuprate prepared in situ from 4-chloro-1-trimethylsilyl-1-butyne, followed by trapping the resulting enolate with Me 3 SiCl, furnished the corresponding silylenol ether 56. The crude product 56 was treated with NaI and mCPBA in THF to give α-iodoketone 54 as a single stereoisomer in 77% yield from the starting material 55. Photolysis of 54 using a sunlamp in the presence of hexamethylditin followed by Bu 3 SnH reduction provided the desired cyclized product 57. cis-Hydrindanone 57 was converted to intermediate 53 in 67% overall yield from 54 via a three-step sequence of reactions including hydrodesilylation of the TMS group, NaBH 4 reduction of the carbonyl function, and acetylation of the resulting alcohol. iodide 52 (cf. Scheme 14) to the generated organoborane 51 in the presence of PdCl 2 (dppf), resulting in the desired coupling product 50. Subsequent deprotection of the TBS group in 50 furnished alcohol 58 in 65% overall yield from 53. After PCC oxidation of 58 (91% yield), the resulting ketone 59 was further transformed to the requisite key intermediate 49 in 52% overall yield by the formation of the silylenol ether followed by Saegusa oxidation [37] .
Completion of the total synthesis of (+)-1 and (−)-2 is depicted in Scheme 17. Conjugate addition of vinylmagnesium bromide to enone 49 afforded the desired adduct 60 with the correct stereochemistry at the C1 and C7a positions. Compound 60 was converted to γ-methylene ketone 61 in 62% overall yield via a three-step operation including Wittig methylenation, deacetylation, and PCC oxidation. Installation of the C5-C6 double bond was achieved by phenylselenation at the C5 position of 61 followed by oxidative elimination, which led to the product 62 (75% yield) 
Ryu's formal synthesis
Synthetic strategy: In 2008, Ryu et al. reported the formal synthesis of (+)-1 and (−)-(2) [21] . The retrosynthetic plan is shown in Scheme 18. The key feature of this scheme is the enantioselective Diels-Alder reaction between known 2-iodo-1,4-quinone monoketal 64 [38, 39] and commercially available 11 using cationic oxazaborolidium catalyst 65 [40] to obtain the optically active endo-Diels-Alder adduct 63 (64 + 11 → 63), which possesses the same absolute configuration as that of the natural products 1 and 2. The Diels-Alder adduct 63 would be transformed to Mehta's intermediate 24, which was already converted to (+)-1 and (−)-2 in six or seven steps by sequential functional group manipulation and deprotection (cf. Schemes 7 and 8). 
Formal synthesis:
The critical enantioselective Diels-Alder reaction was efficiently achieved by stirring a mixture of 64 and 11 in THF in the presence of catalyst 65 (20 mol%) [40] at −78°C (Scheme 19). The desired endo-cycloadduct 63 was produced in 95% yield with excellent enantioselectivity (95% ee). The Diels-Alder adduct 63 was successfully transformed to the key intermediate 24 through a nine-step sequence of reactions as follows. Luche reduction of 63 furnished alcohol 66, which was then subjected to ozonolysis to yield lactol 68 as a mixture of diastereomers via the intermediary dialdehyde 67. Treatment of 68 with DBU provided aldehyde 69 possessing all requisite asymmetric carbon centers in 78% yield in three steps. Wittig methylenation of 69 followed by the removal of the olefinic iodine with n-Bu 3 SnH afforded lactol 70 in 92% yield for the two steps. Subsequent deprotection of the ethylene acetal moiety in 70 followed by PCC oxidation of the lactol moiety provided lactone 71 in 88% yield in two steps. Finally, lactone 71 was converted to the key intermediate 24 by reduction of the enone double bond (87% yield) followed by Wittig methylenation (65% yield). Compound 24 was previously converted to (+)-1 and (−)-2 by Mehta et al. via a six-or seven-step sequence of reactions (cf. Schemes 7 and 8); therefore, the synthesis of 24 represents the formal synthesis of 1and 2.
Conclusion:
In this paper, four independent total syntheses and one formal synthesis of enantiomerically pure (+)-1 and (−)-2 have been reviewed with particular focus on the synthetic strategies. It is interesting to look at the various synthetic methodologies devised for constructing the requisite bicyclic hydrindane skeleton and whole carbon framework by controlling the correct stereochemistry. These synthetic studies hold promise for preparing additional analogues of otteliones A and B with the aim of exploring their structure-activity relationships [41] , which should be useful for the development of novel anticancer agents.
